ArticlePLOS digital health2024
Evaluating Doppel's impact on Anxiety and Focus amongst adults with ADHD.
Article in PLOS digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Digital health technologies for adults with ADHD: a scoping review.Frontiers in digital health · 2026Review
- Wearables in ADHD: Monitoring and Intervention-Where Are We Now?Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children. Amongst adults, it is often underdiagnosed and associated with comorbidities including anxiety. This study presents a trial evaluating the efficacy of Doppel, a wrist-worn wearable that provides vibrations linked to one's heart rate to improve symptoms of anxiety and poor focus amongst young adults with ADHD. Young adults (aged 18-25) used either an active or comparator Doppel for 8 weeks, completing measures of anxiety and focus at baseline, 4 weeks, and 8 weeks. Participants in both groups experienced a reduction in anxiety and an increase in focus across the trial duration. No superiority for vibrations linked to one's heart rate was found. Whilst the current study cannot determine a specific mechanism of action, the findings provide some promising initial evidence as to the potential for direct-to-consumer digital health products to be useful in symptom management amongst young adults with ADHD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.